Summing Up
Thus, epidemiologic methods have contributed to a complex and dynamic understanding of risk of disease in old age, identifying factors that are related to “classical” medical disciplines, such as endocrinology, but also a host of new risk factors that could be regarded as “geriatric.” These latter risk factors tend to be more holistic in that they relate not to one organ system specifically, but identify how even small deficits in multiple organ systems can contribute to risk of poor health outcomes in old age.
The tools and principles of epidemiology have had an important impact on our view of the capabilities and heterogeneity of the older population, on the differentiation of disease from normal aging, on a life-course perspective for risk, and on the types of interventions available to contend with the problems of old age. Many of these contributions have been incorporated in a variety of evidence-based practice guidelines, and the possibilities for the future are bright. Epidemiology can be an important tool to help researchers who study the problems of old age to learn more about the range of health, social, and psychologic problems of the elderly, to identify new avenues for intervention and to test these interventions, and to adapt the interventions to the practical realities of growing old. In this way, epidemiologic method can function as an important adjunct in the mission of promoting independence and providing evidence-based health care for older people.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Webster’s New Twentieth Century Dictionary, 2nd Ed. New York: Simon Schuster; 1979.
Federal Interagency Forum on Aging-Related Statistics. Older American 2000: Key Indicators of Well-Being. Washington, DC: Sauls Lithograph; 2000.
Federal Interagency Forum on Aging-Related Statistics. Older American 2000: Key Indicators of Well-Being. Washington, DC: Sauls Lithograph; 2000. p 19.
Federal Interagency Forum on Aging-Related Statistics. Older American 2000: Key Indicators of Well-Being. Washington, DC: Sauls Lithograph; 2000. pp 24–25.
Manton KG, Stallard E, Corder LS. The dynamics of dimensions of age-related disability 1982 to 1994 in the U.S. elderly population. J Gerontol A Biol Sci Med Sci. 1998;53: B59–B70.
Harris T, Kovar MG, Suzman R, et al. Longitudinal study of physical ability in the oldest-old. Am J Pubic Health. 1989;79:698–702.
Simonsick EM, Newman AB, Nevitt MC, et al. Measuring higher level physical function in well-functioning older adults: Expanding familiar approaches in the Health ABC study. J Gerontol SeriesA-Biol Sci Med Sci. 2001;56: M644–M649.
Guralnik JM, Ferrucci L, Simonsick EM, et al. Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med. 1995; 332:556–561.
Ferrucci L, Guralnik JM, Simonsick EM, et al. Progressive versus catastrophic disability: a longitudinal view of the disablement process. J Gerontol A Biol Sci Med Sci. 1996;51: M123–M130.
Fried LP, Herdman SJ, Juhn K, et al. Preclinical disability: Hypotheses about the bottom of the iceberg. J Aging Health. 1991;3:285–300.
Penninx BW, Guralnik JM, Bandeen-Roche K, et al. The protective effect of emotional vitality on adverse health outcomes in disabled older women. J Am Geriatr Soc. 2000; 48:1359–1366.
Koenig HG, Hays JC, George LK, et al. Modeling the cross-sectional relationships between religion, physical health, social support, and depressive symptoms. Am J Geriatr Psychiatry. 1997;5:131–144.
Bleich HL, Boro ES, Rowe JW. Clinical research on aging: strategies and directions. N Engl J Med. 1977;297:1332–1336.
Herschcopf RJ, Elahi D, Andres R, et al. Longitudinal changes in serum cholesterol in man: An epidemiologic search for an etiology. J Chronic Dis. 1982;35:101–114.
Cline MG, Meredith KE, Boyer JT, et al. Decline of height with age in adults in a general population sample: estimating maximum height and distinguishing birth cohort effects from actural loss of stature with aged. Hum Biol. 1989; 61:415–425.
Schaie KW, Parham IA. Cohort-sequential analyses of adult intellectual development. Dev Psychol. 1977;13:649–653.
White N, Cunningham WR. Is terminal drop pervasive or specific? J Gerontol. 1988;43:P141–P144.
Lindeman RD, Tobin J, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc. 1985;33:278–285.
Stevens J, Cai J, Pamuk ER, et al. The effect of age on the association between body-mass index and mortality. N Engl J Med. 1998;338:1–7.
Diehr P, Bild DE, Harris TB, et al. Body mass index and mortality in nonsmoking older adults: the Cardiovascular Health Study. Am J Public Health. 1998;88:623–629.
Rajala SA, Kanto AJ, Haavisto MV. Body weight and the three-year prognosis in very old peoplez. Int J Obes. 1990; 14:997–1003.
Harris TB, Launer LJ, Madans J, et al. Cohort study of effect of being overweight and change in weight on risk of coronary heart disease in old age. Br Med J. 1997;314:1791–1794.
Busse EW. Biologic and sociologic changes affecting adaptation in mid and late life. Ann Intern Med. 1971;75: 115–120.
Standgaard S, Olesen J, Skinhoj E, et al. Autoregulation of brain circulation in severe arterial hypertension. Br Med J. 1973;1:507–510.
Koch-Weser J. The therapeutic challenge of systolic hypertension. N Engl J Med. 1973;289:481–484.
Main CJ, Masterton G. The influence of hospital environment on blood pressure in psychiatric in-patients. J Psychosom Res. 1981;25:157–163.
Lew EA. High blood pressure, other risk factors and longevity: the insurance viewpoint. Am J Med. 1973;55:281–287.
Shekelle RB, Ostfield AM, Klawans HL Jr. Hypertension and risk of stroke in an elderly population. Stroke. 1974;5: 71–75.
Hypertension Detection and Follow-Up Program Cooperative Group. Five-year findings of the hypertension deterction and follow-up program. II. Mortality by race, sex, and age. JAMA. 1979;242:2572–2577.
Amery A, Birkenhager W, Brixho P, et al. Mortality and morbiditiy results from the European working party on high blood pressure in the elderly trial. Lancet. 1985; i:1349–1354.
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255–3264.
Australian Therapeutic Trial Management Committee. Treatment of mild hypertension in the elderly: a study initiated and administered by the National Heart Foundation of Australia. Med J Aust. 1981;ii:398–402.
Dahlof B, Lindholm LH, Hansson L, et al. Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet. 1991;338:1281–1285.
Price TR, Manolio TA, Kronmal RA, et al. Silent brain infarction on magnetic resonance imaging and neurological abnormalities in community-dwelling older adults. The cardiovascular Health Study. Stroke. 1997;28:1158–1164.
Kostis JB, Davis BR, Cutler J, et al. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group. JAMA. 1997;278:212–216.
Launer LJ, Masaki K, Petrovitch H, et al. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. JAMA. 1995;274:1846–1851.
Kanis JA, Johnell O, Oden A, et al. Risk of hip fracture derived from relative risks: an analysis applied to the population of Sweden. Osteoporosis Int. 2000;11:120–127.
Riggs BL, Melton LJ III. Involutional osteoporosis. N Engl J Med. 1986;314:1676–1686.
Richelson LS, Wahner HW, Melton LJ III, Riggs BL. Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. N Engl J Med. 1984;311:1273–1275.
Cummings SR, Nevitt MC. A hypothesis: the causes of hip fractures. J Gerontol. 1989;44:M107–M111.
Nevitt MC, Cummings SR. Type of fall and risk of hip and wrist fractures: the Study of Osteoporotic Fractures. J Am Geriatr Soc. 1993;41:1226–1234.
Tinetti ME, Speechley M, Ginter ST. Risk factors for falls among elderly persons living in the community. N Engl J Med. 1988;319:1701–1707.
Tinetti ME, Baker DI, McAvay G, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med. 1994;331: 821–827.
Speechley M, Tinnetti M. Falls and injuries in frail and vigorous community elderly persons. J Am Geriatr Soc. 1991;39:46–52.
Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone denisty but without vertebral fractures: results from the Fracture Intervention Trial. JAMA. 1998;280:2077–2082.
Prestwood KM, Gunness M, Muchmore DB, et al. A comparison of the effects of raloxifene and estrogen on bone in postmenopausal women. J Clin Endocrinol Metab. 2000;85: 2197–2202.
The Women’s Health Initiative Study Group. Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials. 1998;19:61–109.
Rights and permissions
Copyright information
© 2003 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Harris, T.B. (2003). Epidemiology and Aging. In: Geriatric Medicine. Springer, New York, NY. https://doi.org/10.1007/0-387-22621-4_5
Download citation
DOI: https://doi.org/10.1007/0-387-22621-4_5
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-95514-8
Online ISBN: 978-0-387-22621-7
eBook Packages: Springer Book Archive